Skip to main content
Blood Advances logoLink to Blood Advances
. 2021 Jun 4;5(11):2515. doi: 10.1182/bloodadvances.2021005066

Gupta V, Kim S, Hu Z-H, et al. Comparison of outcomes of HCT in blast phase of BCR-ABL1 MPN with de novo AML and with AML following MDS. Blood Adv. 2020;4(19):4748-4757.

PMCID: PMC8238488  PMID: 34086861

In “Acknowledgments” on page 4756, National Heart, Lung, and Blood Institute grant T3HL147741 should not have been cited. The error has been corrected in the published article.


Articles from Blood Advances are provided here courtesy of The American Society of Hematology

RESOURCES